17/120
0.7 / 5 stars
All 120 Win/Lose results shown below
KURA Roast Me summary
Kura Oncology, Inc. (KURA). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinKURA / S&P 34.93% / 15.20% |
LoseKURA / S&P KURA unavailable / 15.00% |
LoseKURA / S&P KURA unavailable / 50.40% |
| 2026-Q10/3 |
LoseKURA / S&P -21.75% / -4.33% |
LoseKURA / S&P KURA unavailable / 11.30% |
LoseKURA / S&P KURA unavailable / 27.70% |
| 2025-Q42/3 |
WinKURA / S&P 17.40% / 2.65% |
WinKURA / S&P 25.24% / 9.00% |
LoseKURA / S&P KURA unavailable / 13.40% |
| 2025-Q31/3 |
WinKURA / S&P 53.38% / 8.12% |
LoseKURA / S&P KURA unavailable / 4.61% |
LoseKURA / S&P KURA unavailable / 13.45% |
| 2025-Q20/3 |
LoseKURA / S&P -12.58% / 10.94% |
LoseKURA / S&P KURA unavailable / 4.83% |
LoseKURA / S&P KURA unavailable / 10.63% |
| 2025-Q10/3 |
LoseKURA / S&P -24.23% / -4.27% |
LoseKURA / S&P KURA unavailable / 4.98% |
LoseKURA / S&P KURA unavailable / 10.57% |
| 2024-Q40/3 |
LoseKURA / S&P -55.42% / 2.41% |
LoseKURA / S&P KURA unavailable / 5.25% |
LoseKURA / S&P KURA unavailable / 6.15% |
| 2024-Q30/3 |
LoseKURA / S&P -5.10% / 5.89% |
LoseKURA / S&P KURA unavailable / 5.89% |
LoseKURA / S&P KURA unavailable / 6.11% |
| 2024-Q20/3 |
LoseKURA / S&P -3.47% / 4.28% |
LoseKURA / S&P KURA unavailable / 5.38% |
LoseKURA / S&P KURA unavailable / 5.12% |
| 2024-Q11/3 |
WinKURA / S&P 48.33% / 10.56% |
LoseKURA / S&P KURA unavailable / 5.71% |
LoseKURA / S&P KURA unavailable / 5.59% |
| 2023-Q41/3 |
WinKURA / S&P 57.68% / 11.69% |
LoseKURA / S&P KURA unavailable / 6.81% |
LoseKURA / S&P KURA unavailable / 7.78% |
| 2023-Q30/3 |
LoseKURA / S&P -13.80% / -3.27% |
LoseKURA / S&P KURA unavailable / 7.52% |
LoseKURA / S&P KURA unavailable / -5.03% |
| 2023-Q20/3 |
LoseKURA / S&P -13.49% / 8.74% |
LoseKURA / S&P KURA unavailable / 9.50% |
LoseKURA / S&P KURA unavailable / -8.57% |
| 2023-Q10/3 |
LoseKURA / S&P -1.45% / 7.50% |
LoseKURA / S&P KURA unavailable / 10.77% |
LoseKURA / S&P KURA unavailable / -15.69% |
| 2022-Q40/3 |
LoseKURA / S&P -9.15% / 7.56% |
LoseKURA / S&P KURA unavailable / 11.88% |
LoseKURA / S&P KURA unavailable / -17.99% |
| 2022-Q30/3 |
LoseKURA / S&P -25.48% / -4.88% |
LoseKURA / S&P KURA unavailable / 13.47% |
LoseKURA / S&P KURA unavailable / -1.41% |
| 2022-Q21/3 |
WinKURA / S&P 13.99% / -16.10% |
LoseKURA / S&P KURA unavailable / 13.71% |
LoseKURA / S&P KURA unavailable / 11.04% |
| 2022-Q11/3 |
WinKURA / S&P 14.86% / -4.60% |
LoseKURA / S&P KURA unavailable / 15.97% |
LoseKURA / S&P KURA unavailable / 42.23% |
| 2021-Q40/3 |
LoseKURA / S&P -25.25% / 11.03% |
LoseKURA / S&P KURA unavailable / 15.00% |
LoseKURA / S&P KURA unavailable / 96.40% |
| 2021-Q30/3 |
LoseKURA / S&P -10.17% / 0.58% |
LoseKURA / S&P KURA unavailable / 10.77% |
LoseKURA / S&P KURA unavailable / 69.42% |
| 2021-Q20/3 |
LoseKURA / S&P -26.25% / 8.55% |
LoseKURA / S&P KURA unavailable / 6.58% |
LoseKURA / S&P KURA unavailable / 51.81% |
| 2021-Q10/3 |
LoseKURA / S&P -13.44% / 6.17% |
LoseKURA / S&P KURA unavailable / -1.06% |
LoseKURA / S&P KURA unavailable / 7.39% |
| 2020-Q40/3 |
LoseKURA / S&P 6.59% / 12.15% |
LoseKURA / S&P KURA unavailable / -3.72% |
LoseKURA / S&P KURA unavailable / -33.42% |
| 2020-Q31/3 |
WinKURA / S&P 87.98% / 8.93% |
LoseKURA / S&P KURA unavailable / -2.04% |
LoseKURA / S&P KURA unavailable / -27.10% |
| 2020-Q21/3 |
WinKURA / S&P 63.82% / 20.54% |
LoseKURA / S&P KURA unavailable / -0.46% |
LoseKURA / S&P KURA unavailable / -27.11% |
| 2020-Q10/3 |
LoseKURA / S&P -27.64% / -19.60% |
LoseKURA / S&P KURA unavailable / 3.47% |
LoseKURA / S&P KURA unavailable / -14.75% |
| 2019-Q40/3 |
LoseKURA / S&P -9.36% / 9.07% |
LoseKURA / S&P KURA unavailable / 5.36% |
LoseKURA / S&P KURA unavailable / 2.99% |
| 2019-Q30/3 |
LoseKURA / S&P -22.96% / 1.70% |
LoseKURA / S&P KURA unavailable / 5.02% |
LoseKURA / S&P KURA unavailable / 0.21% |
| 2019-Q21/3 |
WinKURA / S&P 18.69% / 4.30% |
LoseKURA / S&P KURA unavailable / 6.64% |
LoseKURA / S&P KURA unavailable / 8.65% |
| 2019-Q11/3 |
WinKURA / S&P 18.16% / 13.65% |
LoseKURA / S&P KURA unavailable / 8.12% |
LoseKURA / S&P KURA unavailable / 14.29% |
| 2018-Q40/3 |
LoseKURA / S&P -19.77% / -13.52% |
LoseKURA / S&P KURA unavailable / 9.05% |
LoseKURA / S&P KURA unavailable / 18.23% |
| 2018-Q30/3 |
LoseKURA / S&P -3.85% / 7.71% |
LoseKURA / S&P KURA unavailable / 10.21% |
LoseKURA / S&P KURA unavailable / 19.06% |
| 2018-Q20/3 |
LoseKURA / S&P -2.93% / 3.43% |
LoseKURA / S&P KURA unavailable / 9.03% |
LoseKURA / S&P KURA unavailable / 14.46% |
| 2018-Q11/3 |
WinKURA / S&P 22.55% / -0.76% |
LoseKURA / S&P KURA unavailable / 7.68% |
LoseKURA / S&P KURA unavailable / 12.46% |
| 2017-Q40/3 |
LoseKURA / S&P 2.34% / 6.64% |
LoseKURA / S&P KURA unavailable / 7.03% |
LoseKURA / S&P KURA unavailable / 13.82% |
| 2017-Q31/3 |
WinKURA / S&P 60.75% / 4.48% |
LoseKURA / S&P KURA unavailable / 5.68% |
LoseKURA / S&P KURA unavailable / 17.57% |
| 2017-Q21/3 |
WinKURA / S&P 5.68% / 3.09% |
LoseKURA / S&P KURA unavailable / 4.83% |
LoseKURA / S&P KURA unavailable / 17.74% |
| 2017-Q11/3 |
WinKURA / S&P 49.15% / 6.07% |
LoseKURA / S&P KURA unavailable / 3.67% |
LoseKURA / S&P KURA unavailable / 13.32% |
| 2016-Q40/3 |
LoseKURA / S&P -5.60% / 3.82% |
LoseKURA / S&P KURA unavailable / 2.09% |
LoseKURA / S&P KURA unavailable / 7.05% |
| 2016-Q31/3 |
WinKURA / S&P 130.63% / 3.85% |
LoseKURA / S&P KURA unavailable / 0.20% |
LoseKURA / S&P KURA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | KURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 60.19% | 20.78% |
| Annualized return | 60.19% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | KURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -34.74% | 83.14% |
| Annualized return | -8.18% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | KURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 112.69% | 319.30% |
| Annualized return | 7.84% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |